January 29, 2015
COR-003 Phase 3 Study Protocol to be Presented at ENDO 2015: The Endocrine Society’s 97th Annual Meeting & Expo
Media
January 29, 2015
Orexo releases full year report January-December 2014
January 29, 2015
Nordic Nanovector ASA applies for listing of its shares on the Oslo Stock Exchange
January 28, 2015
The Journal Diabetes Publishes Pre-clinical Data on Cortendo’s Novel Diabetes Treatment, BP-2001
January 13, 2015
Cortendo AB Raises up to $27.5M in Additional Private Placement with Leading U.S. and EU Healthcare Investors
January 12, 2015
Ultragenyx Announces Intent to File for Conditional Approval in Europe for Sialic Acid Extended-Release Tablets in Hereditary Inclusion Body Myopathy
January 12, 2015
ONCOS-102 granted US lung cancer orphan drug designation
January 08, 2015
Pulmonx® Acquires Assets of Aeris Therapeutics, Expanding the Company’s Treatment Options for COPD Patients
January 07, 2015
NephroGenex Announces That The European Medicines Agency Supports The Company’s Study Design For Ongoing Trial In Diabetic Nephropathy
January 07, 2015
Report from Aerocrine’s Extraordinary General Meeting